Proton magnetic spectroscopic imaging of the child's brain: The response of tumors to treatment

Neuroradiology

Volumn 43, Issue 2, 2001, Pages 169-177

  Tzika, A A ^a   Zurakowski, D ^a   Poussaint, T Young ^a   Goumnerova, L ^a   Astrakas, L G ^a   Barnes, P D ^a   Anthony, D C ^a   Billett, A L ^a   Tarbell, N J ^a   Scott, R M ^a   Black, P McL ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Brain, tumors; Children; Magnetic resonance spectroscopy

Indexed keywords

ANTINEOPLASTIC AGENT; CHOLINE DERIVATIVE; CREATININE; LACTIC ACID; LIPID; N ACETYLASPARTIC ACID; TUMOR MARKER;

ADOLESCENT; ADULT; ARTICLE; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CELL METABOLISM; CHILD; CHILD CARE; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DISEASE MARKER; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE ENHANCEMENT; IMAGING SYSTEM; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PEDIATRIC SURGERY; PREDICTION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REGRESSION ANALYSIS; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR GROWTH;

ADOLESCENT; ADULT; BRAIN; BRAIN CHEMISTRY; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE;

EID: 0035134376     PISSN: 00283940     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002340000454     Document Type: Article

References (76)

1. What can be learned about childhood cancer from "Cancer statistics review 1973-1988"?
2. Brain tumors in children
3. Pediatric brain tumors
4. Localized proton MR spectroscopy of the brain in children
5. Localized MR spectroscopy of neurodegenerative disease and tumors
6. Intracranial tumors in children: Small single-voxel proton MR spectroscopy using short and long-echo sequences
7. Proton MR spectroscopy of pediatric cerebellar tumors
8. Proton MR spectroscopy of the brain: Clinically useful information obtained in assessing CNS diseases in children
9. 1H-magnetic resonance of pediatric posterior fossa tumors in vitro
10. Proton magnetic resonance spectroscopy of pediatric brain tumors
11. MR image-guided P-31 MR spectroscopy in the evaluation of brain tumor treatment
12. Magnetic resonance spectroscopy (MRS) in the evaluation of pediatric brain tumors. Introduction to MRS
13. Localized high-resolution proton NMR spectroscopy using stimulated echoes: Initial applications to human brain in vivo
14. Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: Initial experience in patients with cerebral tumors
15. Localized proton NMR spectroscopy of brain tumors using short-echo time STEAM sequences
16. Proton magnetic resonance spectroscopy of small lesions (1 ml) localized inside superficial human tumors. A clinical feasibility study
17. Proton chemical shift imaging, metabolic maps, and single voxel spectroscopy of glial brain tumors
18. Single-voxel proton brain spectroscopy exam (PROVE?SV) in patients with primary brain tumors
19. Characterization of intracranial mass lesions with in vivo proton MR spectroscopy
20. Proton MR spectroscopy of intracranial tumors: In vivo and in vitro studies
21. Proton magnetic resonance spectroscopy of brain tumors: An in vitro study
22. Proton magnetic resonance spectroscopy of brain tumors: An in vitro study
23. Quantitative proton spectroscopy of canine brain: In vivo and in vitro correlations
24. Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy
25. Characteristic metabolic profiles revealed by 1H NMR spectroscopy for three types of human brain and nervous system tumours
26. Metabolic imaging of patients with intracranial tumors: H-1 MR spectroscopic imaging and PET
27. Metabolism of human gliomas: Assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET
28. Early metabolic changes following chemotherapy of human gliomas: In vivo demonstrated by phosphorus magnetic resonance spectroscopy
29. Detection of metabolic heterogeneity of human intracranial tumors in vivo by H-1 NMR spectroscopic imaging
30. Mapping of brain tumor metabolites with proton MR spectroscopic imaging: Clinical relevance
31. Proton magnetic resonance spectroscopy in patients with glial tumors: A multicenter study
32. In vivo magnetic resonance spectroscopy of brain tumors
33. Determination of proton metabolite concentrations and relaxation parameters in normal human brain and intracranial tumours
34. In vivo quantitation of metabolite concentrations in the brain by means of proton MRS
35. Clinical applications of proton MR spectroscopy
36. Cystic intracranial mass lesions: Possible role of in vivo MR spectroscopy in differential diagnosis
37. Magnetic resonance spectroscopy (MRS) in the evaluation of pediatric brain tumors. Clinical analysis
38. Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy
39. NMR chemical shift imaging in three dimensions
40. Multivoxel proton MR spectroscopy and hemodynamic MRI of childhood brain tumors: Preliminary observations
41. Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy
42. Atlas of tumor pathology: Tumors of the central nervous system
43. Spatial localization in NMR spectroscopy in vivo
44. A new method for automatic quantification of 1-D spectra with low signal to noise ratio
45. A study of the accuracy of quantification which can be obtained from 1-D NMR spectra using the PIQABLE algorithm
46. An analysis of variance test for normality (complete samples)
47. Correlation between choline level and Gd-DTPA enhancement in patients with brain metastases of mammary carcinoma
48. Human brain tumors: Spectral patterns detected with localized H-1 MR spectroscopy
49. Hydrogen magnetic resonance spectroscopy follow-up after radiation therapy of human brain cancer. Unexpected inverse correlation between the changes in tumor choline level and post-gadolinium magnetic resonance imaging contrast
50. The effect of radiation on normal human CNS as detected by NMR spectroscopy
51. In vivo, ex vivo, and in vivo one-and two-dimensional nuclear magnetic resonance spectroscopy of an intracerebral glioma in rat brain: Assignment of resonance
52. Studies on the distribution of N-acetyl-L-aspartic acid in brain
53. 1H-NMR spectroscopic studies of brain
54. Specific expression of N-acetylaspartate in neurons, oligoden-drocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro
55. 31P NMR spectroscopy of the in vivo metabolism of an intracerebral glioma in the rat
56. Combined 1H-MR imaging and localized 31P-spectroscopy of intracranial tumors in 43 patients
57. Regulation of intracellular creatine in erythrocytes and myoblasts: Influence of uraemia and inhibition of Na, K-AT-Pase
58. A Na(+)-dependent creatine transporter in rabbit brain, muscle, heart, and kidney. cDNA cloning and functional expression
59. Spatially localized in vivo 1H magnetic resonance spectroscopy of an intracerebral rat glioma
60. Relationships among lactate concentration, blood flow and histopathologic profiles in rat C6 glioma
61. Incorporation of lactate measurement in multi-spin-echo proton spectroscopic imaging
62. Localized 2D J-resolved 1H MR spectroscopy of human brain tumors in vivo
63. Irradiation effects on the metabolism of metastatic brain tumors: Analysis by positron emission tomography and 1H-magnetic resonance spectroscopy
64. 1H MR spectroscopy detection of lipids and lactate in metastatic brain tumors
65. Metabolic imaging in the diagnosis of brain tumors
66. Evaluation of metabolic heterogeneity in brain tumors using 1H-chemical shift imaging method
67. Clinical impact of MR spectroscopy when MR imaging is indeterminate for pediatric brain tumors
68. Noninvasive perfusion imaging of human brain tumors with EPISTAR
69. Glial neoplasms: Dynamic contrast-enhanced T2*-weighted MR imaging
70. The in vivo metabolic investigation of brain gliomas with positron emission tomography
71. Comparative value of thallium and glucose SPECT imaging in childhood brain tumors
72. Assessment of malignancy of glioma by positron emission tomography with 18F-fluorodeoxyglucose and single photon emission computed tomography with thallium-201 chloride
73. Technetium-99 m(V)-DMSA and thallium-201 in brain tumor imaging: Correlation with histology and malignant grade